Delivery Order SPE2DB24D2205-SPE2DB25FDXAE

Award Date 1/16/25
Potential Completion Date 1/17/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,139.39 firm-fixed-price contract is to deliver NOVOLOG 100 UNIT/ML VIAL 10ML, a type of insulin medication. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $18,278.64 firm fixed-price contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,455.05, is for the provision of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of February 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,040.98 firm fixed-price contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has a completion date of May 5, 2023 and was awarded on May 4, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.80 firm fixed-price delivery order contract provides for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used in the treatment of diabetes. The contract has an ultimate completion date of November 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,465.84, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used for diabetes management. The contract has a firm fixed price pricing type and a completion date of January 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,534.90, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medication used to treat diabetes. The award was made on May 8, 2023, with a completion date of May 9, 2023. The contract is a firm fixed-price delivery order, with no set-aside requirement. AmerisourceBergen holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,371.87, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medication used to treat diabetes. The contract has an ultimate completion date of November 15, 2024. Amerisourcebergen, a for-profit corporate entity registered in the System for Award Management (SAM.gov), holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,056.62, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication. The contract has a firm fixed price pricing type and an ultimate completion date of March 31, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,021.20 firm fixed price contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a type of insulin medication. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and spanning through November 2026. The IDC covers a comprehensive range of...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDXAE
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,563.65, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a type of insulin medication. The contract has an ultimate completion date of January 17, 2025 and is a firm fixed-price contract. There is no set-aside designation mentioned in the information provided. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/18/25, 2:08 AM